Ireland· IE-PA-PA0126/363/001

Piperacillin/Tazobactam Clonmel 4 g/0.5 g powder for solution for infusion

A piperacillin und beta-lactamase-inhibitor product containing tazobactam + piperacillin, registered in Ireland by Clonmel Healthcare Ltd. The same ATC class is registered in 12 of our 19 countries.

ATC J01CR05

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tazobactam + piperacillinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Piperacillin und beta-lactamase-inhibitor is registered in 12 of 19 countries.

Countries holding a registration under ATC J01CR05 (piperacillin und beta-lactamase-inhibitor), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
8 of them publish a price we can compare per daily dose

Search piperacillin und beta-lactamase-inhibitor products by name

Piperacillin und beta-lactamase-inhibitor · ATC J01CR05

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of piperacillin und beta-lactamase-inhibitor costs, country by country.

Normalised to the WHO defined daily dose (14 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Piperacillin und beta-lactamase-inhibitor · price per daily dose (14 g)

USD · FX 28 Sept 2026

CH Switzerland$158.68

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Tazobactam + Piperacillin
Manufacturer: Clonmel Healthcare Ltd
Country: Ireland (IE)
ATC code: J01CR05
ATC class: Piperacillin und Beta-Lactamase-Inhibitor
Defined daily dose: 14 g, P
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA0126/363/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

111 interactions on record for piperacillin und beta-lactamase-inhibitor.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check piperacillin und beta-lactamase-inhibitor against other medicines How interaction checks work

Piperacillin und beta-lactamase-inhibitor · interactions on record

111 records

5 severe
22 moderate
4 minor
80 info

Most severe, free to view

VancomycinA07AA09severe
VancomycinJ01XA01severe
MethotrexateL01BA01severe
MethotrexateL04AX03severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Piperacillin und beta-lactamase-inhibitor in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All piperacillin und beta-lactamase-inhibitor products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Ibigen
Belgium · Piperacillin/Tazobactam Eg (Eurogenerics), Piperacillin/Tazobactam Eugia
Bulgaria · Piperacillin/Tazobactam Kabi, Перазин
Cyprus · Pazoctam, Piperacillin + Tazobactam Viatris
Czechia · Apiz, Kezutin
Germany · Piperacillin Plus Tazobactam Eberth, Piperacillin/Tazobactam Accord
Denmark · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
Estonia · Eriz, Piperacillin/Tazobactam Eugia
Spain · Piperacilina/Tazobactam Accord Healthcare, Piperacilina/Tazobactam Aurovitas
Finland · Piperacillin / Tazobactam Qilu, Piperacillin/Tazobactam Antibiotice
France · Piperacilline Tazobactam Viatris, Piperacilline/Tazobactam Arrow
United Kingdom (Northern Ireland) · Piperacillin / Tazobactam Qilu, Piperacillin Tazobactam Mylan
Greece · Gramenox, Piperacillin + Tazobactam Viatris
Croatia · Acipirin, Piperacilin/Tazobaktam Accord
Hungary · Piperacillin/Tazobactam Aptapharma, Piperacillin/Tazobactam Kabi
Iceland · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam Sandoz
Italy · Ibitazina, Limerik
Lithuania · Eratia, Piperacillin/Tazobactam Kalceks
Luxembourg · Piperacillin/Tazobactam Eurogenerics, Piperacillin/Tazobactam Kabi
Latvia · Eratia, Piperacillin/Tazobactam Eugia
Malta · Piperacillin Tazobactam Viatris, Piperacillin/Tazobactam Aptapharma
Netherlands · Piperacillin/Tazobactam Tillomed, Piperacilline/Tazobactam Accord
Norway · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
Poland · Piperacillin + Tazobactam Accord, Piperacillin + Tazobactam Aptapharma
Portugal · Piperacilina + Tazobactam Accord, Piperacilina + Tazobactam Aurobindo
Romania · Perasin, Piperacilină/Tazobactam Aptapharma
Sweden · Piperacillin/Tazobactam Antibiotice, Piperacillin/Tazobactam B. Braun
Slovenia · Piperacilin/Tazobaktam Accord, Piperacilin/Tazobaktam Aptapharma
Slovakia · Piperacilin Comp. Sandoz, Piperacillin/Tazobactam Aptapharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/b68982fd-06b8-43ae-a37a-ecbe453fe940
GET /v1/drugs/b68982fd-06b8-43ae-a37a-ecbe453fe940?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01CR05"
  ],
  "strength": null,
  "pa_number": "PA0126/363/001",
  "substances": [
    "Tazobactam",
    "Piperacillin"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "19/08/2022",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about piperacillin und beta-lactamase-inhibitor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console